Catalent (CTLT) Tops Q4 EPS by 7c, Revenues Miss; Offers FY19 Revenue Outlook Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Catalent, Inc. Reports Fourth Quarter Fiscal 2018 Results
August 28, 2018 7:30 AM EDTQ4'18 revenue of $685.3 million increased 11% as-reported, or 9% in constant currency from the prior-year period. Full-year revenue of $2,463.4 million increased 19% as-reported, or 16% in constant currency from the prior-year. Closed the acquisition of Juniper Pharmaceuticals, a European early development Center of Excellence with dose form development and clinical manufacturing capabilities. Issued 11,431,411 shares of common stock at a price to the public of $40.24, raising approximately $445 million of net proceeds used to pay down USD Term Loan floating-rate debt.... More
